The Diagnosis and Management of Inherited Bleeding Disorders

Musculoskeletal Aspects of Haemophilia

Volumn , Issue , 2008, Pages 3-10

  White, B ^a   Lee, C A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Haemostatic response; Inherited bleeding disorders; Postoperative care; Spontaneous haemarthrosis; Surgical management

Indexed keywords

EID: 15944363720     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470693872.ch1     Document Type: Chapter

References (21)

1. Ragni MV, Tegtmeier GE, Levy JA et al. AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations. Blood 1986; 67: 592-5.
2. Lee CA, Kernoff PB, Karayiannis P, Thomas HC. Acute fulminant non-A, non-B hepatitis leading to chronic active hepatitis after treatment with cryoprecipitate. Gut 1985; 26:639-41.
3. Rickard KA, Batey RG, Dority P, Johnson S, Campbell J, Hodgson J. Hepatitis and haemophilia therapy in Australia. Lancet 1982; 2: 146-8.
4. Colombo M, Mannucci PM, Carnelli V, Savidge GF, Gazengel C, Schimpf K. Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate. Lancet 1985; 2: 1-4.
5. Lim SG, Lee CA, Charman H, Tilsed G, Griffiths PD, Kernoff PB. Hepatitis C antibody assay in a longitudinal study of haemophiliacs. Br J Haematol 1991; 78: 398402.
6. Makris M, Preston FE, Triger DR et al. Hepatitis C antibody and chronic liver disease in haemophilia.Lancet 1990; 335: 1117-19.
7. Lawlor E, Johnson Z, Thornton L, Temperley I. Investigation of an outbreak of hepatitis A in Irish haemophilia A patients. Vox Sang 1994; 67 (Suppl. 1): 18-19.
8. Mannucci PM, Gdovin S, Gringeri A et al. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group. Ann Intern Med 1994; 120: 1-7.
9. Evatt BL. Prions and haemophilia: assessment of risk. Haemophilia 1998; 4: 628-33.
10. Nilsson IM, Berntorp E, Freiburghaus C. Treatment of patients with factor VIII and IX inhibitors. Thromb Haemost 1993; 70: 56-9.
11. Martinowitz U, Schulman S, Gitel S, Horozowski H, Heim M, Varon D. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A. Br J Haematol 1992; 82: 729-34.
12. Varon D, Martinowitz U. Continuous infusion therapy in haemophilia. Haemophilia 1998; 4: 431-5.
13. Lusher JM, Arkin S, Abildgaard CF, Schwartz RS. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group. N Engl J Med 1993; 328: 453-9.
14. Addiego J, Kasper C, Abildgaard C et al. Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII. Lancet 1993; 342: 462-4.
15. Hay CR, Colvin BT, Ludlam CA, Hill FG, Preston FE. Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working Party. Blood Coagul Fibrinolysis 1996; 7: 134-8.
16. Gringeri A, Santagostino E, Mannucci PM. Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody. Haemostasis 1991; 21: 1-4.
17. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997; 90: 2515-21.
18. Shouval D. Vaccines for prevention of viral hepatitis. Haemophilia 1998; 4: 587-94.
19. Wilde JT, Lee CA, Collins P, Giangrande PL, Winter M, Shiach CR. Increased bleeding associated with protease inhibitor therapy in HIV-positive patients with bleeding disorders. Br J Haematol 1999; 107: 556-9.
20. Rickard KA. Guidelines for therapy and optimal dosing of coagulation factor for treatment of bleeding and surgery in haemophilia. Haemophilia 1995; 1 (Suppl.): 8-13.
21. Kobrinsky NL, Stegman DA. Management of haemophilia during surgery. In: Forbes CD, Adelort L, Madhok R, eds. Haemophilia. London: Chapman and Hall, 1997: 239-48.